We continue to add to the data set and encourage feedback
SAMPLING GUIDE IS STILL BEING CONSTRUCTED

SAMPLING GUIDE

Search our guide by Method, Compound or CAS#

Note: Type in the parameter you are looking for and once you search, you can expand fields for more details. This guide contains industrial and active pharmaceutical compounds.
Compound Name CAS# Method / Equivalent    RL Matrix Media Option 1 Media Alternative Flow Rate (LPM)
1,3-dicyclohexylurea 2387-23-7 NAT-2008-18125 iom5a 2.0
+
14-hydroxycodienone hcl 508-54-3 NAT-2004-08399 iom5a 2.0
NAT-2004-08399 0.2 µg sw2 n/a
+
17 alpha hydroxyprogesterone caproate 630-56-8 NAT-2009-20309 3 ng tfe3a 2.0
NAT-2009-20309 12.5 µg tx74 n/a
17-a-hydroxyprogesterone 630-56-8 NAT-2008-18988 0.05 µg tfe3a 2.0
+
17-beta estradiol 50-28-2 NAT-2001-00963 0.01 µg nyl 2.0
NAT-2001-00963 0.01 µg pzr5 2.0 lpm
NAT-2005-11561 0.6 ng iom5a 2.0 liters per minute
NAT-2005-11561 10 µg sw2 n/a
NAT-2008-19288 0.6 ng tfe3a 2.0 liters per minute
NAT-2001-00963 0.01 µg bel3 2.0 liters per minute
NAT-2001-00963 1 µg sw2 n/a
+
17-deacetylnorgestimate NAT-2001-00932 0.4 µg sw2 n/a
NAT-2001-00932 0.01 µg tfe3a n/a
1-h-pyrazole-1-carboxamidine hydrochlori 4023-02-3 NAT-2005-11941 0.05 µg iom4 2.0
+
5-fluorouracil 51-21-8 NAT-2006-14764 1 µg bel2 2.0
MODIFIED NAT-2006-14764 1 µg skc 226-30-16 / ovs2 1.0 lpm
NAT-2009-20269 0.02 µg tfe3a 2.0 liters per minute
BV-2011-22371 0.015 µg tx74 n/a
NAT-2006-14764 1 µg tx74 n/a
NAT-2006-14764 1 µg tx76 n/a
NAT-2006-14764 1 µg sw2 n/a
6-amino penicillanic acid 551-16-6 NAT-2001-01322 1 µg iom1 2.0
+
acamprosate calcium 77337-73-6 NAT-2008-17584 4.8 µg bel4 2.0
NAT-2008-17584 4.8 µg tx74 n/a
acebutolol hcl 34381-68-5 NAT-2002-03552 0.5 µg bel6 2.0
acetaldehyde (stel) 75-07-0 OSHA 68 3.3 µg skc 226-54 / xadb 0.05
Compound Name CAS# Method / Equivalent    RL Matrix Media Option 1 Media Alternative Flow Rate (LPM)
1,3-dicyclohexylurea 2387-23-7 NAT-2008-18125 iom5a 2.0
+
14-hydroxycodienone hcl 508-54-3 NAT-2004-08399 iom5a 2.0
NAT-2004-08399 0.2 µg sw2 n/a
+
17 alpha hydroxyprogesterone caproate 630-56-8 NAT-2009-20309 3 ng tfe3a 2.0
NAT-2009-20309 12.5 µg tx74 n/a
17-a-hydroxyprogesterone 630-56-8 NAT-2008-18988 0.05 µg tfe3a 2.0
+
17-beta estradiol 50-28-2 NAT-2001-00963 0.01 µg nyl 2.0
NAT-2001-00963 0.01 µg pzr5 2.0 lpm
NAT-2005-11561 0.6 ng iom5a 2.0 liters per minute
NAT-2005-11561 10 µg sw2 n/a
NAT-2008-19288 0.6 ng tfe3a 2.0 liters per minute
NAT-2001-00963 0.01 µg bel3 2.0 liters per minute
NAT-2001-00963 1 µg sw2 n/a
+
17-deacetylnorgestimate NAT-2001-00932 0.4 µg sw2 n/a
NAT-2001-00932 0.01 µg tfe3a n/a
1-h-pyrazole-1-carboxamidine hydrochlori 4023-02-3 NAT-2005-11941 0.05 µg iom4 2.0
+
5-fluorouracil 51-21-8 NAT-2006-14764 1 µg bel2 2.0
MODIFIED NAT-2006-14764 1 µg skc 226-30-16 / ovs2 1.0 lpm
NAT-2009-20269 0.02 µg tfe3a 2.0 liters per minute
BV-2011-22371 0.015 µg tx74 n/a
NAT-2006-14764 1 µg tx74 n/a
NAT-2006-14764 1 µg tx76 n/a
NAT-2006-14764 1 µg sw2 n/a
6-amino penicillanic acid 551-16-6 NAT-2001-01322 1 µg iom1 2.0
+
acamprosate calcium 77337-73-6 NAT-2008-17584 4.8 µg bel4 2.0
NAT-2008-17584 4.8 µg tx74 n/a
acebutolol hcl 34381-68-5 NAT-2002-03552 0.5 µg bel6 2.0
acetaldehyde (stel) 75-07-0 OSHA 68 3.3 µg skc 226-54 / xadb 0.05
Compound Name CAS# Method / Equivalent    RL Matrix Media Option 1 Media Alternative Flow Rate (LPM)
1,3-dicyclohexylurea 2387-23-7 NAT-2008-18125 iom5a 2.0
+
14-hydroxycodienone hcl 508-54-3 NAT-2004-08399 iom5a 2.0
NAT-2004-08399 0.2 µg sw2 n/a
+
17 alpha hydroxyprogesterone caproate 630-56-8 NAT-2009-20309 3 ng tfe3a 2.0
NAT-2009-20309 12.5 µg tx74 n/a
17-a-hydroxyprogesterone 630-56-8 NAT-2008-18988 0.05 µg tfe3a 2.0
+
17-beta estradiol 50-28-2 NAT-2001-00963 0.01 µg nyl 2.0
NAT-2001-00963 0.01 µg pzr5 2.0 lpm
NAT-2005-11561 0.6 ng iom5a 2.0 liters per minute
NAT-2005-11561 10 µg sw2 n/a
NAT-2008-19288 0.6 ng tfe3a 2.0 liters per minute
NAT-2001-00963 0.01 µg bel3 2.0 liters per minute
NAT-2001-00963 1 µg sw2 n/a
+
17-deacetylnorgestimate NAT-2001-00932 0.4 µg sw2 n/a
NAT-2001-00932 0.01 µg tfe3a n/a
1-h-pyrazole-1-carboxamidine hydrochlori 4023-02-3 NAT-2005-11941 0.05 µg iom4 2.0
+
5-fluorouracil 51-21-8 NAT-2006-14764 1 µg bel2 2.0
MODIFIED NAT-2006-14764 1 µg skc 226-30-16 / ovs2 1.0 lpm
NAT-2009-20269 0.02 µg tfe3a 2.0 liters per minute
BV-2011-22371 0.015 µg tx74 n/a
NAT-2006-14764 1 µg tx74 n/a
NAT-2006-14764 1 µg tx76 n/a
NAT-2006-14764 1 µg sw2 n/a
6-amino penicillanic acid 551-16-6 NAT-2001-01322 1 µg iom1 2.0
+
acamprosate calcium 77337-73-6 NAT-2008-17584 4.8 µg bel4 2.0
NAT-2008-17584 4.8 µg tx74 n/a
acebutolol hcl 34381-68-5 NAT-2002-03552 0.5 µg bel6 2.0
acetaldehyde (stel) 75-07-0 OSHA 68 3.3 µg skc 226-54 / xadb 0.05
Compound Name CAS# Method / Equivalent    RL Matrix Media Option 1 Media Alternative Flow Rate (LPM)
1,3-dicyclohexylurea 2387-23-7 NAT-2008-18125 iom5a 2.0
+
14-hydroxycodienone hcl 508-54-3 NAT-2004-08399 iom5a 2.0
NAT-2004-08399 0.2 µg sw2 n/a
+
17 alpha hydroxyprogesterone caproate 630-56-8 NAT-2009-20309 3 ng tfe3a 2.0
NAT-2009-20309 12.5 µg tx74 n/a
17-a-hydroxyprogesterone 630-56-8 NAT-2008-18988 0.05 µg tfe3a 2.0
+
17-beta estradiol 50-28-2 NAT-2001-00963 0.01 µg nyl 2.0
NAT-2001-00963 0.01 µg pzr5 2.0 lpm
NAT-2005-11561 0.6 ng iom5a 2.0 liters per minute
NAT-2005-11561 10 µg sw2 n/a
NAT-2008-19288 0.6 ng tfe3a 2.0 liters per minute
NAT-2001-00963 0.01 µg bel3 2.0 liters per minute
NAT-2001-00963 1 µg sw2 n/a
+
17-deacetylnorgestimate NAT-2001-00932 0.4 µg sw2 n/a
NAT-2001-00932 0.01 µg tfe3a n/a
1-h-pyrazole-1-carboxamidine hydrochlori 4023-02-3 NAT-2005-11941 0.05 µg iom4 2.0
+
5-fluorouracil 51-21-8 NAT-2006-14764 1 µg bel2 2.0
MODIFIED NAT-2006-14764 1 µg skc 226-30-16 / ovs2 1.0 lpm
NAT-2009-20269 0.02 µg tfe3a 2.0 liters per minute
BV-2011-22371 0.015 µg tx74 n/a
NAT-2006-14764 1 µg tx74 n/a
NAT-2006-14764 1 µg tx76 n/a
NAT-2006-14764 1 µg sw2 n/a
6-amino penicillanic acid 551-16-6 NAT-2001-01322 1 µg iom1 2.0
+
acamprosate calcium 77337-73-6 NAT-2008-17584 4.8 µg bel4 2.0
NAT-2008-17584 4.8 µg tx74 n/a
acebutolol hcl 34381-68-5 NAT-2002-03552 0.5 µg bel6 2.0
acetaldehyde (stel) 75-07-0 OSHA 68 3.3 µg skc 226-54 / xadb 0.05
Compound Name CAS# Method / Equivalent    RL Matrix Media Option 1 Media Alternative Flow Rate (LPM)
1,3-dicyclohexylurea 2387-23-7 NAT-2008-18125 iom5a 2.0
+
14-hydroxycodienone hcl 508-54-3 NAT-2004-08399 iom5a 2.0
NAT-2004-08399 0.2 µg sw2 n/a
+
17 alpha hydroxyprogesterone caproate 630-56-8 NAT-2009-20309 3 ng tfe3a 2.0
NAT-2009-20309 12.5 µg tx74 n/a
17-a-hydroxyprogesterone 630-56-8 NAT-2008-18988 0.05 µg tfe3a 2.0
+
17-beta estradiol 50-28-2 NAT-2001-00963 0.01 µg nyl 2.0
NAT-2001-00963 0.01 µg pzr5 2.0 lpm
NAT-2005-11561 0.6 ng iom5a 2.0 liters per minute
NAT-2005-11561 10 µg sw2 n/a
NAT-2008-19288 0.6 ng tfe3a 2.0 liters per minute
NAT-2001-00963 0.01 µg bel3 2.0 liters per minute
NAT-2001-00963 1 µg sw2 n/a
+
17-deacetylnorgestimate NAT-2001-00932 0.4 µg sw2 n/a
NAT-2001-00932 0.01 µg tfe3a n/a
1-h-pyrazole-1-carboxamidine hydrochlori 4023-02-3 NAT-2005-11941 0.05 µg iom4 2.0
+
5-fluorouracil 51-21-8 NAT-2006-14764 1 µg bel2 2.0
MODIFIED NAT-2006-14764 1 µg skc 226-30-16 / ovs2 1.0 lpm
NAT-2009-20269 0.02 µg tfe3a 2.0 liters per minute
BV-2011-22371 0.015 µg tx74 n/a
NAT-2006-14764 1 µg tx74 n/a
NAT-2006-14764 1 µg tx76 n/a
NAT-2006-14764 1 µg sw2 n/a
6-amino penicillanic acid 551-16-6 NAT-2001-01322 1 µg iom1 2.0
+
acamprosate calcium 77337-73-6 NAT-2008-17584 4.8 µg bel4 2.0
NAT-2008-17584 4.8 µg tx74 n/a
acebutolol hcl 34381-68-5 NAT-2002-03552 0.5 µg bel6 2.0
acetaldehyde (stel) 75-07-0 OSHA 68 3.3 µg skc 226-54 / xadb 0.05
Compound Name CAS# Method / Equivalent    RL Matrix Media Option 1 Media Alternative Flow Rate (LPM)
1,3-dicyclohexylurea 2387-23-7 NAT-2008-18125 iom5a 2.0
+
14-hydroxycodienone hcl 508-54-3 NAT-2004-08399 iom5a 2.0
NAT-2004-08399 0.2 µg sw2 n/a
+
17 alpha hydroxyprogesterone caproate 630-56-8 NAT-2009-20309 3 ng tfe3a 2.0
NAT-2009-20309 12.5 µg tx74 n/a
17-a-hydroxyprogesterone 630-56-8 NAT-2008-18988 0.05 µg tfe3a 2.0
+
17-beta estradiol 50-28-2 NAT-2001-00963 0.01 µg nyl 2.0
NAT-2001-00963 0.01 µg pzr5 2.0 lpm
NAT-2005-11561 0.6 ng iom5a 2.0 liters per minute
NAT-2005-11561 10 µg sw2 n/a
NAT-2008-19288 0.6 ng tfe3a 2.0 liters per minute
NAT-2001-00963 0.01 µg bel3 2.0 liters per minute
NAT-2001-00963 1 µg sw2 n/a
+
17-deacetylnorgestimate NAT-2001-00932 0.4 µg sw2 n/a
NAT-2001-00932 0.01 µg tfe3a n/a
1-h-pyrazole-1-carboxamidine hydrochlori 4023-02-3 NAT-2005-11941 0.05 µg iom4 2.0
+
5-fluorouracil 51-21-8 NAT-2006-14764 1 µg bel2 2.0
MODIFIED NAT-2006-14764 1 µg skc 226-30-16 / ovs2 1.0 lpm
NAT-2009-20269 0.02 µg tfe3a 2.0 liters per minute
BV-2011-22371 0.015 µg tx74 n/a
NAT-2006-14764 1 µg tx74 n/a
NAT-2006-14764 1 µg tx76 n/a
NAT-2006-14764 1 µg sw2 n/a
6-amino penicillanic acid 551-16-6 NAT-2001-01322 1 µg iom1 2.0
+
acamprosate calcium 77337-73-6 NAT-2008-17584 4.8 µg bel4 2.0
NAT-2008-17584 4.8 µg tx74 n/a
acebutolol hcl 34381-68-5 NAT-2002-03552 0.5 µg bel6 2.0
acetaldehyde (stel) 75-07-0 OSHA 68 3.3 µg skc 226-54 / xadb 0.05